BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 29093267)

  • 61. Gegen Qinlian Decoction abates nonalcoholic steatohepatitis associated liver injuries via anti-oxidative stress and anti-inflammatory response involved inhibition of toll-like receptor 4 signaling pathways.
    Zhang CH; Xiao Q; Sheng JQ; Liu TT; Cao YQ; Xue YN; Shi M; Cao Z; Zhou LF; Luo XQ; Deng KZ; Chen C
    Biomed Pharmacother; 2020 Jun; 126():110076. PubMed ID: 32169759
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Targeting hepatic miR-221/222 for therapeutic intervention of nonalcoholic steatohepatitis in mice.
    Jiang X; Jiang L; Shan A; Su Y; Cheng Y; Song D; Ji H; Ning G; Wang W; Cao Y
    EBioMedicine; 2018 Nov; 37():307-321. PubMed ID: 30316865
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis.
    Csak T; Bala S; Lippai D; Kodys K; Catalano D; Iracheta-Vellve A; Szabo G
    PLoS One; 2015; 10(6):e0129251. PubMed ID: 26042593
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Indole supplementation ameliorates MCD-induced NASH in mice.
    Zhu B; Li H; Lu B; Guo X; Wu C; Wang F; Li Q; Xie L; Glaser S; Francis H; Alpini G; Wu C
    J Nutr Biochem; 2022 Sep; 107():109041. PubMed ID: 35568098
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis.
    Wang T; Sun G; Wang Y; Li S; Zhao X; Zhang C; Jin H; Tian D; Liu K; Shi W; Tian Y; Zhang D
    FASEB J; 2019 Jul; 33(7):8490-8503. PubMed ID: 30951375
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis.
    Uno M; Kurita S; Misu H; Ando H; Ota T; Matsuzawa-Nagata N; Kita Y; Nabemoto S; Akahori H; Zen Y; Nakanuma Y; Kaneko S; Takamura T
    Hepatology; 2008 Jul; 48(1):109-18. PubMed ID: 18571789
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.
    Marcolin E; San-Miguel B; Vallejo D; Tieppo J; Marroni N; González-Gallego J; Tuñón MJ
    J Nutr; 2012 Oct; 142(10):1821-8. PubMed ID: 22915297
    [TBL] [Abstract][Full Text] [Related]  

  • 71. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
    Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
    Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
    Luo XY; Takahara T; Kawai K; Fujino M; Sugiyama T; Tsuneyama K; Tsukada K; Nakae S; Zhong L; Li XK
    Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice.
    Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
    Int Immunopharmacol; 2019 Oct; 75():105797. PubMed ID: 31421545
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
    Ip E; Farrell GC; Robertson G; Hall P; Kirsch R; Leclercq I
    Hepatology; 2003 Jul; 38(1):123-32. PubMed ID: 12829994
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism.
    Tao HC; Chen KX; Wang X; Chen B; Zhao WO; Zheng Y; Yang YG
    Front Immunol; 2020; 11():148. PubMed ID: 32158445
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice.
    Maina V; Sutti S; Locatelli I; Vidali M; Mombello C; Bozzola C; Albano E
    Clin Sci (Lond); 2012 Jun; 122(11):545-53. PubMed ID: 22142284
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
    Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
    Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    Zhang YH; Ma Q; Ding P; Li J; Chen LL; Ao KJ; Tian YY
    Yonsei Med J; 2018 Nov; 59(9):1064-1071. PubMed ID: 30328321
    [TBL] [Abstract][Full Text] [Related]  

  • 79. TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice.
    Yang L; Miura K; Zhang B; Matsushita H; Yang YM; Liang S; Song J; Roh YS; Seki E
    Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):469-483. PubMed ID: 28462384
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8
    Muñoz-Durango N; Arrese M; Hernández A; Jara E; Kalergis AM; Cabrera D
    Front Immunol; 2020; 11():563434. PubMed ID: 33391254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.